Table 5.
Initial sample | Post-cefotetan | |
---|---|---|
ABO | A | A |
Rh phenotype | DEce | DEce, mixed field |
DAT | ||
IgG | 2+ | 4+ |
C3 | w+ | vw+ |
Antibody screen | Negative | 3+* |
Positive at AHG phase with all cells
Initial sample | Post-cefotetan | |
---|---|---|
ABO | A | A |
Rh phenotype | DEce | DEce, mixed field |
DAT | ||
IgG | 2+ | 4+ |
C3 | w+ | vw+ |
Antibody screen | Negative | 3+* |
Positive at AHG phase with all cells